273 related articles for article (PubMed ID: 6715398)
21. The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications.
Meinhold-Heerlein I; Fotopoulou C; Harter P; Kurzeder C; Mustea A; Wimberger P; Hauptmann S; Sehouli J
Arch Gynecol Obstet; 2016 Apr; 293(4):695-700. PubMed ID: 26894303
[TBL] [Abstract][Full Text] [Related]
22. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
[TBL] [Abstract][Full Text] [Related]
23. Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006-2015.
Krugmann J; Schwarz CL; Melcher B; Sterlacci W; Ozalinskaite A; Lermann J; Agaimy A; Vieth M
Arch Gynecol Obstet; 2019 Feb; 299(2):515-523. PubMed ID: 30415435
[TBL] [Abstract][Full Text] [Related]
24. Recurrent urothelial carcinoma-like FGFR3 genomic alterations in malignant Brenner tumors of the ovary.
Lin DI; Killian JK; Venstrom JM; Ramkissoon SH; Ross JS; Elvin JA
Mod Pathol; 2021 May; 34(5):983-993. PubMed ID: 33077920
[TBL] [Abstract][Full Text] [Related]
25. [New cytogenetic classification of precancerous lesions and carcinomas of the endometrium: possibilities and limits of immunohistochemical differentiation].
Dallenbach-Hellweg G
Verh Dtsch Ges Pathol; 1991; 75():357-62. PubMed ID: 1724841
[TBL] [Abstract][Full Text] [Related]
26. Unusual cystadenofibromas: endometrioid, mucinous, and clear cell types.
Kao GF; Norris HJ
Obstet Gynecol; 1979 Dec; 54(6):729-36. PubMed ID: 514560
[TBL] [Abstract][Full Text] [Related]
27. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
McCluggage WG
Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of Endometriosis in Malignant Epithelial Ovarian Tumor.
Akbarzadeh-Jahromi M; Shekarkhar G; Sari Aslani F; Azarpira N; Heidari Esfahani M; Momtahan M
Arch Iran Med; 2015 Dec; 18(12):844-8. PubMed ID: 26621017
[TBL] [Abstract][Full Text] [Related]
29. Precursor lesions of ovarian epithelial malignancy.
Feeley KM; Wells M
Histopathology; 2001 Feb; 38(2):87-95. PubMed ID: 11207821
[TBL] [Abstract][Full Text] [Related]
30. ras oncogene product p21 expression and prognosis of human ovarian tumors.
Yaginuma Y; Yamashita K; Kuzumaki N; Fujita M; Shimizu T
Gynecol Oncol; 1992 Jul; 46(1):45-50. PubMed ID: 1634140
[TBL] [Abstract][Full Text] [Related]
31. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
Ramalingam P
Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
[TBL] [Abstract][Full Text] [Related]
32. [Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?].
Devouassoux-Shisheboran M; Genestie C; Ray-Coquard I
Bull Cancer; 2016 Mar; 103(3):252-8. PubMed ID: 26853278
[TBL] [Abstract][Full Text] [Related]
33. FOXA1 is expressed in ovarian mucinous neoplasms.
Karpathiou G; Venet M; Mobarki M; Forest F; Chauleur C; Peoc'h M
Pathology; 2017 Apr; 49(3):271-276. PubMed ID: 28238418
[TBL] [Abstract][Full Text] [Related]
34. Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas.
RodrÃguez IM; Prat J
Am J Surg Pathol; 2002 Feb; 26(2):139-52. PubMed ID: 11812936
[TBL] [Abstract][Full Text] [Related]
35. Demonstration of neuroendocrine cells in ovarian mucinous tumors.
Sasaki E; Sasano N; Kimura N; Andoh N; Yajima A
Int J Gynecol Pathol; 1989; 8(3):189-200. PubMed ID: 2570045
[TBL] [Abstract][Full Text] [Related]
36. Invasive ovarian endometrioid adenofibroma with omental implants and collision with endometrial adenocarcinoma.
Gaing AA; Kimble CC; Belmonte AH; Agustin E; Tchertkoff V
Obstet Gynecol; 1988 Mar; 71(3 Pt 2):440-4. PubMed ID: 3347431
[TBL] [Abstract][Full Text] [Related]
37. Mixed Ovarian Neoplasms With Gastrointestinal-type Mucinous and Mullerian Epithelial Components: A Rare Group of Tumors Demonstrating the Phenotypic Plasticity of the Mullerian Epithelial Cell.
Chui MH; Ellenson LH
Am J Surg Pathol; 2023 Jul; 47(7):756-765. PubMed ID: 37125505
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
McCluggage WG; Young RH
Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors.
Yasunaga M; Ohishi Y; Oda Y; Misumi M; Iwasa A; Kurihara S; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
Hum Pathol; 2009 Jul; 40(7):965-74. PubMed ID: 19269675
[TBL] [Abstract][Full Text] [Related]
40. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis.
Rutgers JL; Scully RE
Cancer; 1988 Jan; 61(2):340-8. PubMed ID: 3334969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]